According to Indonesian media outlet Mediaindonesia, Indonesia is expected to complete the derivative regulations of the "Health Law 2023" by the end of 2023. These regulations will include provisions on the protection of addictive substances in tobacco and e-cigarette products.
Previously, the Indonesian Minister of Health, Budi Gunadi Sadikin, stated that this derivative regulation could be completed as early as the end of September 2022. Siti Nadia Tarmizi, the Director of Public Service and Communication Bureau at the Indonesian Ministry of Health, expressed in an interview that the process of drafting the regulation is still ongoing. Despite the lengthy timeline, there have been no instances of deadlock in the discussions surrounding the regulation.
Diah Satyani Saminarsih, the founder and CEO of the Indonesia Strategic Development Initiative Center (CISDI), has highlighted several major issues in healthcare legislation and regulations. These include the management of healthcare workers, the integration of primary health services, healthcare for non-communicable diseases, the protection of addictive substances in tobacco and e-cigarette products, emergency response to abnormal conditions and outbreaks, healthcare financing, community participation, and governance of guidance and supervision.
Nevertheless, Dia stated that we still believe there is a need for further in-depth discussion on the various components of hygiene regulations.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
